Syngene International rises on incorporating wholly owned subsidiary
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Syngene International is currently trading at Rs. 602.65, up by 1.55 points or 0.26% from its previous closing of Rs. 601.10 on the BSE.
The scrip opened at Rs. 585.25 and has touched a high and low of Rs. 611.95 and Rs. 585.25 respectively. So far 23566 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 686.00 on 15-Sep-2021 and a 52 week low of Rs. 508.10 on 22-Feb-2022.
Last one week high and low of the scrip stood at Rs. 619.65 and Rs. 571.30 respectively. The current market cap of the company is Rs. 24324.92 crore.
The promoters holding in the company stood at 70.29%, while Institutions and Non-Institutions held 18.33% and 11.39% respectively.
Syngene International has incorporated wholly owned subsidiary company namely ‘Syngene Manufacturing Solutions’ (SMSL) on August 26, 2022. SMSL shall be engaged in the business of manufacturing of pharmaceutical, biopharmaceutical and biological products of any kind. The company has acquired is 10 lakh equity shares of Rs 10 each aggregating to Rs 1 crore.
Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large Oligonucleotide, Antibody-Drug Conjugates and Oligonucleotides.
